Does Rallies show Form 4 insider transactions for PACS?

Yes. Rallies tracks PACS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PACS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PACS. It does not provide personalized investment advice.

PACS (PACS Group, Inc.) Stock Analysis - Insider Trades

PACS Group, Inc. (PACS) is a publicly traded Financial Services sector company. As of May 21, 2026, PACS trades at $37.00 with a market cap of $5.83B and a P/E ratio of 29.72. PACS moved +0.53% today. Year to date, PACS is -6.97%; over the trailing twelve months it is +251.04%. Its 52-week range spans $7.50 to $43.92. Analyst consensus is strong buy with an average price target of $48.80. Rallies surfaces PACS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PACS stock inside the company?

Recent PACS insider activity includes MITCHELL JOHN TODD sold 24.09K, MITCHELL JOHN TODD sold 3.30K, MITCHELL JOHN TODD sold 45.95K, MITCHELL JOHN TODD sold 6.81K, and Jergensen Joshua sold 36.34K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PACS Key Metrics

Key financial metrics for PACS
Metric	Value
Price	$37.00
Market Cap	$5.83B
P/E Ratio	29.72
EPS	$1.23
Dividend Yield	0.00%
52-Week High	$43.92
52-Week Low	$7.50
Volume	0
Avg Volume	0
Revenue (TTM)	$5.29B
Net Income	$191.46M
Gross Margin	0.00%

Recent PACS Insider Trades

MITCHELL JOHN TODD sold 24.09K (~$892.25K) on May 18, 2026.
MITCHELL JOHN TODD sold 3.30K (~$125.44K) on May 18, 2026.
MITCHELL JOHN TODD sold 45.95K (~$1.74M) on May 15, 2026.
MITCHELL JOHN TODD sold 6.81K (~$263.98K) on May 15, 2026.
Jergensen Joshua sold 36.34K (~$1.25M) on Mar 13, 2026.

Latest PACS News

PACS Group Inc to Report Q1 2026 Results as Investors Weigh Value Versus Medpace — May 11, 2026
PACS Group climbs as investors position ahead of May 11 Q1 results catalyst — May 6, 2026
PACS Group climbs after setting Q1 earnings date for May 11 and call May 12 — May 5, 2026
PACS slides as investor focus returns to legal probes and compliance overhang — Apr 28, 2026
PACS Group rises 3% as analyst-upside spotlight rekindles buying interest — Apr 27, 2026

PACS Analyst Consensus

5 analysts cover PACS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.80.

Common questions about PACS

Who is trading PACS stock inside the company?: Recent PACS insider activity includes MITCHELL JOHN TODD sold 24.09K, MITCHELL JOHN TODD sold 3.30K, MITCHELL JOHN TODD sold 45.95K, MITCHELL JOHN TODD sold 6.81K, and Jergensen Joshua sold 36.34K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PACS?: Yes. Rallies tracks PACS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PACS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PACS. It does not provide personalized investment advice.